{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "8d41edce",
   "metadata": {},
   "source": [
    "# Explore label examples\n",
    "This notebook is for exploring the annotations for the individual label to get a better insight into the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "bad6ca89",
   "metadata": {},
   "outputs": [],
   "source": [
    "from spacy.tokens import DocBin\n",
    "import spacy\n",
    "import random\n",
    "\n",
    "# Initialize NLP object\n",
    "nlp = spacy.blank(\"en\")\n",
    "\n",
    "# Get participants docs from training data\n",
    "participants_path = \"../corpus/ner_train_p.spacy\"\n",
    "participants_docBin = DocBin().from_disk(participants_path)\n",
    "participants_docs = list(participants_docBin.get_docs(nlp.vocab))\n",
    "\n",
    "# Get intervention docs from training data\n",
    "intervention_path = \"../corpus/ner_train_i.spacy\"\n",
    "intervention_docBin = DocBin().from_disk(intervention_path)\n",
    "intervention_docs = list(intervention_docBin.get_docs(nlp.vocab))\n",
    "\n",
    "# Get intervention docs from training data\n",
    "outcome_path = \"../corpus/ner_train_o.spacy\"\n",
    "outcome_docBin = DocBin().from_disk(outcome_path)\n",
    "outcome_docs = list(outcome_docBin.get_docs(nlp.vocab))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1b729525",
   "metadata": {},
   "source": [
    "## Label [Participants]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "86cc9011",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 metastatic colorectal cancer : 4\n",
      "1 southern Italy cooperative oncology group trials . 7\n",
      "2 metastatic colorectal cancer ( CRC ) . 7\n",
      "3 254 patients 2\n",
      "4 elderly patients . 3\n",
      "0 older heart failure patients : 5\n",
      "0 patients with large or locally advanced HER2-positive ( HER2+ ) breast cancers 12\n",
      "1 core biopsy samples from 27 HER2+ breast cancer patients enrolled in a preoperative clinical trial using trastuzumab , nab-paclitaxel and carboplatin combination therapy ( BrUOG BR-211B ( NCT00617942 ) ) . 31\n",
      "2 18 weeks of treatment , 5\n",
      "0 health education intervention trials : 5\n",
      "1 health education research . 4\n",
      "2 mixed RCT/preference trial comparing two formats 6\n",
      "3 Women take PRIDE heart disease management program . 8\n",
      "4 women 1\n",
      "0 elderly oncologic hypertensive patients : 5\n",
      "1 Elderly neoplastic patients 3\n",
      "2 hypertension and hyperuricemia 3\n",
      "3 hypertensive neoplastic elderly patients . 5\n",
      "4 Seventy patients with cancer 4\n",
      "5 hypertension and hyperuricemia in elderly patients under chemotherapeutic treatment . 10\n",
      "0 malignant melanoma . 3\n",
      "1 malignant melanoma . 3\n",
      "2 patients with high-risk melanoma 4\n",
      "3 the patients had lesions greater than 1.70 mm thick and TNM stage IB or stage II disease . 18\n",
      "4 coumarin-treated group of 13 patients , and 10 recurrences in the placebo-treated group of 14 patients 16\n",
      "0 head-and-neck cancer patients . 4\n",
      "1 patients with head-and-neck squamous cell carcinomas . 7\n",
      "2 65 patients with head-and-neck squamous cell carcinoma nodal metastasis 9\n",
      "3 Fifty-four patients had sufficient tumor cells for comet analysis 9\n",
      "0 chronic obstructive pulmonary disease . 5\n",
      "1 10 patients with chronic obstructive pulmonary disease 7\n",
      "2 patients with chronic obstructive pulmonary disease . 7\n",
      "0 patients with metastatic breast cancer : 6\n",
      "1 Three hundred two patients with no previous chemotherapy for MBC 10\n",
      "2 patients with no previous chemotherapy for MBC . 8\n",
      "0 Eighty patients undergoing gynecological tumor resection 6\n",
      "1 RESULTS A total of 79 patients were evaluated . The 10\n"
     ]
    }
   ],
   "source": [
    "# Show 10 random spans marked with the participant label\n",
    "random.shuffle(participants_docs)\n",
    "for doc in participants_docs[:10]:\n",
    "    for i,ent in enumerate(doc.ents):\n",
    "        print(i,ent, len(ent))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "fcb668ee",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0-7: 9479 (69.65%)\n",
      "0: 3 (0.02%)\n",
      "1: 604 (4.44%)\n",
      "2: 1424 (10.46%)\n",
      "3: 2033 (14.94%)\n",
      "4: 1914 (14.06%)\n",
      "5: 1548 (11.37%)\n",
      "6: 1067 (7.84%)\n",
      "7: 886 (6.51%)\n",
      "8: 656 (4.82%)\n",
      "9: 467 (3.43%)\n",
      "10: 379 (2.78%)\n",
      "11: 332 (2.44%)\n",
      "12: 244 (1.79%)\n",
      "13: 202 (1.48%)\n",
      "14: 201 (1.48%)\n",
      "15: 181 (1.33%)\n",
      "16: 158 (1.16%)\n",
      "17: 135 (0.99%)\n",
      "18: 126 (0.93%)\n",
      "19: 114 (0.84%)\n",
      "20: 96 (0.71%)\n",
      "21: 95 (0.7%)\n",
      "22: 83 (0.61%)\n",
      "23: 64 (0.47%)\n",
      "24: 77 (0.57%)\n",
      "25: 45 (0.33%)\n",
      "26: 31 (0.23%)\n",
      "27: 40 (0.29%)\n",
      "28: 40 (0.29%)\n",
      "29: 29 (0.21%)\n",
      "30: 24 (0.18%)\n",
      "31: 19 (0.14%)\n",
      "32: 27 (0.2%)\n",
      "33: 24 (0.18%)\n",
      "34: 19 (0.14%)\n",
      "35: 19 (0.14%)\n",
      "36: 15 (0.11%)\n",
      "37: 13 (0.1%)\n",
      "38: 15 (0.11%)\n",
      "39: 17 (0.12%)\n",
      "40: 8 (0.06%)\n",
      "41: 6 (0.04%)\n",
      "42: 11 (0.08%)\n",
      "43: 10 (0.07%)\n",
      "44: 7 (0.05%)\n",
      "45: 8 (0.06%)\n",
      "46: 8 (0.06%)\n",
      "47: 9 (0.07%)\n",
      "48: 10 (0.07%)\n",
      "49: 5 (0.04%)\n",
      "50: 6 (0.04%)\n",
      "51: 4 (0.03%)\n",
      "52: 2 (0.01%)\n",
      "53: 7 (0.05%)\n",
      "54: 1 (0.01%)\n",
      "55: 5 (0.04%)\n",
      "56: 4 (0.03%)\n",
      "57: 4 (0.03%)\n",
      "58: 1 (0.01%)\n",
      "62: 1 (0.01%)\n",
      "63: 3 (0.02%)\n",
      "64: 2 (0.01%)\n",
      "65: 2 (0.01%)\n",
      "66: 1 (0.01%)\n",
      "67: 2 (0.01%)\n",
      "69: 1 (0.01%)\n",
      "70: 2 (0.01%)\n",
      "71: 3 (0.02%)\n",
      "75: 1 (0.01%)\n",
      "76: 1 (0.01%)\n",
      "77: 2 (0.01%)\n",
      "79: 2 (0.01%)\n",
      "81: 1 (0.01%)\n",
      "86: 1 (0.01%)\n",
      "95: 1 (0.01%)\n",
      "97: 1 (0.01%)\n",
      "115: 1 (0.01%)\n"
     ]
    }
   ],
   "source": [
    "# Create a list of span lengths for the participant label\n",
    "participant_lengths = {}\n",
    "for doc in participants_docs:\n",
    "    for ent in doc.ents:\n",
    "        ent_len = 0\n",
    "        for token in ent:\n",
    "            if not token.is_stop:\n",
    "                ent_len+= 1\n",
    "        if ent_len not in participant_lengths:\n",
    "            participant_lengths[ent_len] = 0\n",
    "        participant_lengths[ent_len] += 1\n",
    "        \n",
    "participant_sum = 0\n",
    "\n",
    "for ent_len in participant_lengths:\n",
    "    participant_sum += participant_lengths[ent_len]\n",
    "\n",
    "range_max = 7\n",
    "range_sum = 0\n",
    "for i in range(0,range_max+1):\n",
    "    range_sum += participant_lengths[i]\n",
    "    \n",
    "print(f\"0-{range_max}: {range_sum} ({round((range_sum/participant_sum)*100,2)}%)\")\n",
    "    \n",
    "for ent_len in sorted(participant_lengths.keys()) :        \n",
    "    print(f\"{ent_len}: {participant_lengths[ent_len]} ({round((participant_lengths[ent_len]/participant_sum)*100,2)}%)\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f257be4a",
   "metadata": {},
   "source": [
    "## Label [Intervention]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "a22a41f1",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 inpatient Dialectical Behavior Therapy ( DBT )\n",
      "1 standard outpatient DBT ,\n",
      "2 receive 12 weeks of intensified inpatient DBT plus six months of standard DBT ,\n",
      "0 all-norgestrel\n",
      "1 dl-norgestrel alone\n",
      "2 estradiol-17 beta alone\n",
      "3 combined hormones\n",
      "4 placebo control\n",
      "5 dl-norgestrel\n",
      "6 dl-norgestrel\n",
      "0 careful estimates\n",
      "1 public commitment , self-consistency\n",
      "2 unique causal risk models .\n",
      "3 risk anchor based on downward social comparison processes\n",
      "4 comparison anchors\n",
      "0 New drug trials\n",
      "0 recombinant human granulocyte-macrophage colony-stimulating factor\n",
      "1 Recombinant murine GM-CSF administration\n",
      "2 recombinant human ( rhu ) GM-CSF\n",
      "3 placebo\n",
      "4 rhuGM-CSF\n",
      "5 rhuGM-CSF .\n",
      "6 rhuGM-CSF\n",
      "7 rhuGM-CSF .\n",
      "8 rhuGM-CSF\n",
      "9 rhuGM-CSF\n",
      "10 rhuGM-CSF\n",
      "0 adenosine myocardial perfusion imaging\n",
      "1 adenosine myocardial perfusion imaging\n",
      "2 Coronary angiography was conducted within 6 weeks of an adenosine thallium-201 myocardial perfusion imaging study .\n",
      "3 adenosine thallium-201 myocardial perfusion imaging\n",
      "0 remote ischemic perconditioning\n",
      "1 Remote ischemic perconditioning ( RIPerc )\n",
      "2 RIPerc\n",
      "3 the control group ( n = 100 ) . RIPerc was\n",
      "4 the RIPerc group\n",
      "5 CONCLUSIONS RIPerc applied\n",
      "0 receive or not to receive diagnostic information and counseling directives on\n",
      "1 binary logistic regression\n",
      "2 physician counseling and improvements\n",
      "0 Aloe and Placebo\n",
      "1 Powder\n",
      "2 aloe extract\n",
      "3 moist cream\n",
      "4 dry powder skin care regimen .\n",
      "5 powder , aloe cream\n",
      "6 placebo cream .\n",
      "7 aloe extract\n",
      "0 yoga versus stretching\n",
      "1 complementary and alternative medicine ( CAM ) therapies . Yoga\n",
      "2 yoga\n",
      "3 self care and exercise\n",
      "4 12 weekly yoga classes , 12 weekly conventional therapeutic exercise classes of comparable physical exertion , or a self-care book .\n",
      "5 yoga\n",
      "6 yoga\n",
      "7 yoga\n",
      "8 yoga\n",
      "0 UGIE with sedation ( 0.1 mg/kg of midazolam )\n",
      "1 without it ( two endoscopies per volunteer in random order ) were monitored throughout the procedure by means of electrocardiogram , blood pressure and peripheral oxygen saturation ( SpO2 ) . Cardiac output was measured at six points before , during and after endoscopy from automated cardiac flow measurement by color Doppler echocardiography .\n",
      "2 midazolam\n",
      "0 bladder flap\n",
      "1 cesarean delivery :\n",
      "2 bladder flap\n",
      "3 cesarean deliveries\n",
      "4 primary and repeat cesarean deliveries\n",
      "5 creation\n",
      "6 omission\n",
      "7 abdominal surgeries\n",
      "8 cesarean deliveries\n",
      "9 omission of the bladder flap\n",
      "0 Total parenteral nutrition with glutamine dipeptide\n",
      "0 antilymphocyte globulin , cyclosporine and two different granulocyte colony-stimulating factor regimens :\n",
      "1 treated with anti-lymphocyte globulin ( ALG ) , cyclosporin ( CyA ) and granulocyte colony-stimulating factor ( G-CSF ) 5 micro g/kg/day\n",
      "2 higher dose of G-CSF ( 10 micro g/kg/day )\n",
      "3 horse ALG ( 15 mg/kg/day day1-5 ) and CyA ( 5 mg/kg/day day 1-180 ) .\n",
      "4 receive G-CSF 5 micro g/kg/day ( n=38 , group A ) or 10 micro g/kg/day ( n=39 , group B ) from day +1 to day +30 . All patients then received G-CSF 5 micro g/kg/day from day +31 to day +90 .\n",
      "5 G-CSF\n",
      "6 ALG and CyA .\n",
      "0 iron\n",
      "1 formula milk with no added iron against the same formula milk containing 1.2 mg of iron per 100 ml .\n",
      "2 iron\n",
      "3 iron\n"
     ]
    }
   ],
   "source": [
    "random.shuffle(intervention_docs)\n",
    "for doc in intervention_docs[:15]:\n",
    "    for i,ent in enumerate(doc.ents):\n",
    "        print(i,ent)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2038fd02",
   "metadata": {},
   "source": [
    "## Label [Outcome]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "c62c6ff7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 proteinuria\n",
      "1 proteinuria-lowering effect of a renin inhibitor ( aliskiren )\n",
      "2 reduced proteinuria . These\n",
      "3 Furthermore , 24-h proteinuria was\n",
      "4 significantly reduced proteinuria . The antiproteinuric effect is\n",
      "5 with chronic proteinuric non-diabetic kidney disease .\n",
      "0 advanced colorectal cancer :\n",
      "1 5-fluorouracil\n",
      "2 partial response\n",
      "3 complete\n",
      "4 partial response\n",
      "5 Time to failure\n",
      "6 median survival time\n",
      "7 Diarrhea , stomatitis and vomiting\n",
      "8 nonhematologic toxicities\n",
      "9 hematologic toxicity was leukopenia ;\n",
      "10 advanced colorectal cancer\n",
      "0 language\n",
      "1 behavioral symptoms\n",
      "2 assessments of language , behavior , and autism symptomatology .\n",
      "3 mean scores on any measure of language , behavior , or autism symptom severity\n",
      "0 incidence of clinical sepsis .\n",
      "1 incidence of positive blood cultures , necrotising enterocolitis ( NEC ) stage II or III , or death , and the duration of hospital stay .\n",
      "2 incidence of clinical sepsis\n",
      "3 Mortality\n",
      "4 blood cultures\n",
      "5 incidence of NEC and the duration of hospital stay\n",
      "0 pulmonary hypertension\n",
      "1 pulmonary pressure\n",
      "2 Postoperative PA pressure\n",
      "3 PA/Ao pressure\n",
      "4 Pulmonary hypertensive crisis\n",
      "5 PA pressure\n",
      "6 significant complications\n",
      "7 pulmonary hypertension\n",
      "0 abstinence .\n",
      "1 abstinence outcomes\n",
      "2 baseline characteristics and posttreatment and follow-up cocaine outcomes\n",
      "3 durations of cocaine abstinence\n",
      "4 cocaine-negative sample\n",
      "5 outcomes\n",
      "6 cocaine abstinence\n",
      "0 survival\n",
      "1 median observation time\n",
      "2 Kaplan-Meier curves\n",
      "3 no lymph node involvement\n",
      "4 nodal spread of tumor cells\n",
      "5 long-term survival\n",
      "6 improved overall survival\n",
      "7 survival\n",
      "8 locoregional spread of cancer cells .\n",
      "0 pain and rescue analgesic demand\n",
      "1 Postoperative pain scores\n",
      "2 rescue analgesics\n",
      "3 analgesic time\n",
      "4 Postoperative nausea\n",
      "5 vomiting\n",
      "6 sedation , confusion , and pruritus\n",
      "0 motor response to acute treatment with levodopa\n",
      "1 bioavailability\n",
      "2 duration of the motor response to levodopa\n",
      "3 Plasma levodopa concentrations\n",
      "4 latency to onset of motor response\n",
      "5 prolonging the duration of the benefit\n",
      "0 contrast sensitivity\n",
      "1 contrast sensitivity\n",
      "2 statistically significantly better contrast sensitivity\n",
      "3 contrast sensitivity\n",
      "0 LTA results\n",
      "1 arachidonic acid stimulated aggregation\n",
      "2 Clopidogrel intake\n",
      "3 low-response to clopidogrel .\n",
      "4 collagen-epinephrine stimulated PFA-100 results\n",
      "5 platelet inhibition by aspirin and clopidogrel assessed by aggregometry\n",
      "0 immunological parameters\n",
      "1 Th1 cells ( IFN-gamma-positive CD4 ( + ) T cells ) , Th2 cells ( IL-4-positive CD4 ( + ) T cells ) , Th1/Th2 ratio , NKT cells ( CD56 ( + ) T cells and CD57 ( + ) T cells ) , NK cells , and CD25 ( + ) CD4 ( + ) T cells\n",
      "2 3-year overall survival\n",
      "3 Th1 cells , Th2 cells , Th1/Th2 ratio , CD56 ( + ) T cells , CD57 ( + ) T cells , NK cells , and CD4 ( + ) CD25 ( + ) T cells\n",
      "4 CD57 ( + ) T cells\n",
      "5 3-year survival\n",
      "0 clinical outcome ( morbidity and mortality )\n",
      "0 cerebral hemodynamic response\n",
      "1 concentration of oxyhemoglobin and deoxyhemoglobin\n",
      "2 concentrations of oxyhemoglobin and total levels of hemoglobin\n",
      "3 cerebral blood flow\n",
      "4 hemodynamic\n",
      "5 cognitive performance .\n"
     ]
    }
   ],
   "source": [
    "random.shuffle(outcome_docs)\n",
    "for doc in outcome_docs[:15]:\n",
    "    for i,ent in enumerate(doc.ents):\n",
    "        print(i,ent)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
